MOESM4 of The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

Name: MOESM4 of The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
Published: 2018-04-13T05:00:00Z
Keywords: Rectal cancer, Resistance to neoadjuvant radio-chemotherapy, 5-Fluorouracil, Proteomics, Mass spectrometry, Predictive biomarkers, Biochemistry, Medicine, Genetics, Molecular Biology, Physiology, Ecology, Biological Sciences not elsewhere classified, Developmental Biology, Infectious Diseases

Cite Download Share Embed

MOESM4 of The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

2018-04-13T05:00:00Z (GMT) by AnaĂŻs Chauvin Chang-Shu Wang Sameh Geha Perrine Garde-Granger Alex-Ane Mathieu Vincent Lacasse FranĂ§ois-Michel Boisvert

Additional file 4: Table S4. Proteins differentially expressed between PR and PR.

Keyword(s)

Rectal cancer Resistance to neoadjuvant radio-chemotherapy 5-Fluorouracil Proteomics Mass spectrometry Predictive biomarkers

License

CC BY + CC0

Export

RefWorks

BibTeX

Endnote

DataCite

NLM